GALECTIN THERAPEUTICS INC (GALT) Operating Lease, Liability USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Galectin Therapeutics Inc quarterly Operating Lease, Liability history and growth rate from 2019 to 2024.
  • Galectin Therapeutics Inc Operating Lease, Liability for the quarter ending March 31, 2024 was $55 K, a 43.3% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $55 K -$42 K -43.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $66 K -$40 K -37.7% Dec 31, 2023 10-K 2024-03-29
Q3 2023 $77 K -$39 K -33.6% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $86 K -$29 K -25.2% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $97 K -$14 K -12.6% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $106 K +$98 K +1225% Dec 31, 2022 10-K 2023-03-30
Q3 2022 $116 K +$97 K +511% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $115 K +$84 K +271% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $111 K +$69 K +164% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $8 K -$44 K -84.6% Dec 31, 2021 10-K 2022-03-31
Q3 2021 $19 K -$43 K -69.4% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $31 K -$41 K -56.9% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $42 K -$39 K -48.1% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $52 K -$38 K -42.2% Dec 31, 2020 10-K 2021-03-31
Q3 2020 $62 K -$37 K -37.4% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $72 K -$36 K -33.3% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $81 K -$34 K -29.6% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $90 K Dec 31, 2019 10-K 2020-03-16
Q3 2019 $99 K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $108 K Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $115 K Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.